Suppr超能文献

有证据表明,具有钙拮抗剂特性的药物地尔硫䓬不具有β-肾上腺素受体阻断活性。

Evidence against beta-adrenoceptor blocking activity of diltiazem, a drug with calcium antagonist properties.

作者信息

Briley M, Cavero I, Langer S Z, Roach A G

出版信息

Br J Pharmacol. 1980 Aug;69(4):669-73. doi: 10.1111/j.1476-5381.1980.tb07920.x.

Abstract

1 The isolated spontaneously beating atria of the rat, diltiazem (0.01 to 0.1 microM) shifted the atrial rate concentration-response curves to isoprenaline to the right in a non-parallel manner and depressed their maxima. Under the same experimental conditions, (+/-)-propranolol (0.03 to 0.1 microM) behaved as a competitive beta-adrenoceptor antagonist. 2 Whereas (+/-)-propranolol (IC50 = 12 nM) and isoprenaline (IC50 = 0.9 microM) inhibited (-)-[3H]-dihydroalprenolol binding to rat brain membrane preparations, diltiazem failed to do so in concentrations up to 10 microM. 3 Diltiazem but not (+/-)-propranolol, antagonized the positive chronotropic responses to calcium in spontaneously beating rat atria. 4 It is proposed that diltiazem inhibited the tachycardia induced by isoprenaline through an effect on calcium which may be an essential modulator of the sequence of events linking the beta-adrenoceptor activation and heart rate response.

摘要
  1. 大鼠离体自发搏动的心房,地尔硫䓬(0.01至0.1微摩尔)以非平行方式使异丙肾上腺素的心房率浓度 - 反应曲线右移,并降低其最大值。在相同实验条件下,(±) - 普萘洛尔(0.03至0.1微摩尔)表现为竞争性β - 肾上腺素能受体拮抗剂。2. 虽然(±) - 普萘洛尔(IC50 = 12纳摩尔)和异丙肾上腺素(IC50 = 0.9微摩尔)抑制( - ) - [3H] - 二氢阿普洛尔与大鼠脑膜制剂的结合,但地尔硫䓬在浓度高达10微摩尔时未能做到这一点。3. 地尔硫䓬而非(±) - 普萘洛尔,拮抗自发搏动的大鼠心房对钙的正性变时反应。4. 有人提出,地尔硫䓬通过对钙的作用抑制异丙肾上腺素诱导的心动过速,钙可能是连接β - 肾上腺素能受体激活与心率反应的一系列事件的重要调节因子。

相似文献

本文引用的文献

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验